- Home
- BCRX vs IIPR Comparison
BCRX vs IIPR Comparison
Compare BCRX & IIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BCRX | IIPR |
|---|---|---|
| Founded | 1986 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.8B |
| IPO Year | 1995 | 2016 |
Fundamental Metrics
Financial Performance| Metric | BCRX | IIPR |
|---|---|---|
| Price | $8.02 | $49.73 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 6 |
| Target Price | $20.73 | ★ $64.50 |
| AVG Volume (30 Days) | ★ 4.9M | 319.4K |
| Earning Date | 11-02-2026 | 11-02-2026 |
| Dividend Yield | N/A | ★ 15.04% |
| EPS Growth | ★ 381.40 | N/A |
| EPS | N/A | ★ 2.39 |
| Revenue | $25,186,000.00 | ★ $265,955,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.02 | $4.03 |
| P/E Ratio | ★ N/A | $21.13 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.00 | $44.58 |
| 52 Week High | $11.22 | $65.38 |
Technical Indicators
Market Signals| Indicator | BCRX | IIPR |
|---|---|---|
| Relative Strength Index (RSI) | 35.10 | 22.28 |
| Support Level | $6.35 | $48.51 |
| Resistance Level | $8.05 | $51.68 |
| Average True Range (ATR) | 0.30 | 1.11 |
| MACD | -0.02 | -0.58 |
| Stochastic Oscillator | 14.16 | 0.68 |
Price Performance
Historical ComparisonAbout BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About IIPR Innovative Industrial Properties Inc.
Innovative Industrial Properties Inc is a real estate investment trust focused on the acquisition, ownership and management of specialized industrial and commercial properties in the United States. Its properties are prominently leased to state-licensed operators for their regulated cannabis facilities. The company conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by its Operating Partnership, directly or through subsidiaries. Its segments are: Cannabis Portfolio and Life Science Portfolio, with the majority of revenue coming from the Cannabis Portfolio segment, which involves acquiring, developing, and leasing real estate to regulated cannabis operators on long-term triple-net leases.